BAG2 is a target of the c-Myc gene and is involved in cellular senescence via the p21 CIP1 pathway

Cancer Letters

Volumn 318, Issue 1, 2012, Pages 34-41

  Zhang, Ju ^a   Lou, Xiaomin ^a   Yang, Shangbin ^b,c   He, Shun ^b   Yang, Lei ^a   Liu, Mei ^b   Zhu, Hongxia ^b   Shan, Qiang ^a   Su, Siyuan ^a   Zhan, Qimin ^b   Xu, Ningzhi ^b   Liu, Siqi ^a  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b CANCER HOSPITAL   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

BAG2; C Myc; P21 CIP1; Senescence; SP1

Indexed keywords

BCL2 ASSOCIATED ATHANOGENE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCL2 ASSOCIATED ATHANOGENE 2 GENE; CANCER CELL CULTURE; CELL AGING; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GENE; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUCIFERASES; MICE; MICE, NUDE; MOLECULAR CHAPERONES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84857141264     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.033     Document Type: Article

References (30)

1. Collado M., Serrano M. Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 2010, 10:51-57.
2. Shay J.W., Wright W.E. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett. 2010, 584:3819-3825.
3. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 2003, 63:2705-2715.
4. Patel J.H., Loboda A.P., Showe M.K., Showe L.C., McMahon S.B. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 2004, 4:562-568.
5. Hydbring P., Bahram F., Su Y., Tronnersjö S., Högstrand K., von der Lehr N., et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc. Natl. Acad. Sci. USA 2010, 107:58-63.
6. Hydbring P., Larsson L.G. Tipping the balance: Cdk2 enables Myc to suppress senescence. Cancer Res. 2010, 70:6687-6691.
7. Wu C.H., van Riggelen J., Yetil A., Fan A.C., Bachireddy P., Felsher D.W. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc. Natl. Acad. Sci. USA 2007, 104:13028-13033.
8. Guney I., Wu S., Sedivy J.M. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc. Natl. Acad. Sci. USA 2006, 103:3645-3650.
9. Kotake Y., Cao R., Viatour P., Sage J., Zhang Y., Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev. 2007, 21:49-54.
10. Rakhra K., Bachireddy P., Zabuawala T., Zeiser R., Xu L., Kopelman A., et al. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 2010, 16:485-498.
11. Doong H., Vrailas A., Kohn E.C. What's in the 'BAG'? - a functional domain analysis of the BAG-family proteins. Cancer Lett. 2002, 188:25-32.
12. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J.A., Reed J.C. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 1995, 80:279-284.
13. Wang H.G., Takayama S., Rapp U.R., Reed J.C. Bcl-2 interacting protein, BAG-1 binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 1996, 93:7063-7068.
14. Arndt V., Daniel C., Nastainczyk W., Alberti S., Höhfeld J. BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol. Biol. Cell 2005, 16:5891-5900.
15. Dai Q., Qian S.B., Li H.H., McDonough H., Borchers C., Huang D., et al. Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J. Biol. Chem. 2005, 280:38673-38681.
16. Min J.N., Whaley R.A., Sharpless N.E., Lockyer P., Portbury A.L., Patterson C. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol. Cell Biol. 2008, 28:4018-4025.
17. Doong H., Price J., Kim Y.S., Gasbarre C., Probst J., Liotta L.A., et al. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 2000, 19:4385-4395.
18. Qian H., Wang T., Naumovski L., Lopez C.D., Brachmann R.K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 2002, 21:7901-7911.
19. Gartel A.L., Shchors K. Mechanisms of c-Myc-mediated transcriptional repression of growth arrest genes. Exp. Cell Res. 2003, 1:17-21.
20. Narita M., Nnez S., Heard E., Narita M., Lin A.W., Hearn S.A., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
21. Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M., et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 2005, 8:19-30.
22. McConnell B.B., Starborg M., Brookes S., Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 1998, 8:351-354.
23. Diolaiti D., Della V.G., Perini G., Marshall G.M. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc. Natl. Acad. Sci. USA 2007, 104:18682-18687.
24. Burrows A.E., Smogorzewska A., Elledge S.J. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc. Natl. Acad. Sci. USA 2010, 107:14280-14285.
25. Feng X.H., Liang Y.Y., Liang M., Zhai W., Lin X. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β mediated induction of the CDK inhibitor p15INK4b. Mol. Cell 2002, 9:133-143.
26. Gartel A.L., Ye X., Goufman E., Shianov P., Hay N., Najmabadi F., Tyner A.L. Myc represses the p21WAF1/CIP1 promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. USA 2001, 98:4510-4515.
27. Liu H., Zhou M., Luo X., Zhang L., Niu Z., Peng C., et al. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc. BMC Mol. Biol. 2008, 9:111.
28. Nozawa K., Maehara K., Isobe K. Mechanism for the reduction of telomerase expression during muscle cell differentiation. J. Biol. Chem. 2001, 276:22016-22023.
29. Zhuang D., Mannava S., Grachtchouk V., Tang W.H., Patil S., Wawrzyniak J.A., et al. c-Myc overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 2008, 6:6623-6634.
30. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., et al. BRAFE600-associated senescence like cell cycle arrest of human naevi. Nature 2005, 436:720-724.